Results from a phase I study of andecaliximab in combination with paclitaxel in patients with previously untreated metastatic breast cancer

Hamilton, EP; Bessudo, A; Bruetman, D; Gordon, MS; Patel, R; Adewoye, AH

JOURNAL OF CLINICAL ONCOLOGY, 2018; 36 (15):